{"id":"W1968655366","doi":"10.1016/j.cgh.2012.06.032","title":"Therapeutic Drug Monitoring of Tumor Necrosis Factor Antagonists in Inflammatory Bowel Disease","year":2012,"lang":"en","type":"review","venue":"Clinical Gastroenterology and Hepatology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":211,"is_retracted":false,"has_abstract":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Drug; Pharmacokinetics; Ulcerative colitis; Certolizumab pegol; Inflammatory bowel disease; Therapeutic drug monitoring; Tumor necrosis factor alpha; Disease; Internal medicine; Clinical trial; Infliximab; Pharmacology; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000577141,0.0005719017,0.001641789,0.000173604,0.00006054578,0.00001267858,0.0004583895,0.0006418346,0.00003035799],"category_scores_gemma":[0.0001380101,0.00052161,0.0006588982,0.00004658912,0.0009096453,0.000009886164,0.0004197458,0.0006815899,0.0000193769],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003054729,"about_ca_system_score_gemma":0.0003515289,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004670265,"about_ca_topic_score_gemma":0.00004632538,"domain_scores_codex":[0.9952782,0.001376964,0.001671674,0.0008199228,0.0001071245,0.0007460593],"domain_scores_gemma":[0.9978333,0.0001609241,0.0007635613,0.0007134632,0.00006271108,0.0004660905],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000869635,0.0002609798,0.9770376,0.003469095,0.0002507605,0.0002035672,0.00001376353,2.103715e-7,0.000005968063,0.00003536764,0.00004983857,0.01780323],"study_design_scores_gemma":[0.001405639,0.0003035205,0.8983949,0.0009061502,0.000892624,0.00008902836,0.00001443781,0.000005123697,0.000004503223,0.00004465105,0.09751147,0.0004278827],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.4770947,0.5217206,0.000006373383,0.00002231748,0.0006735238,0.0003714227,0.00009271772,0.00001120836,0.000007127162],"genre_scores_gemma":[0.2499056,0.7491008,0.00005936762,0.0002065005,0.0003957804,0.0001306111,0.0001037727,0.00006224846,0.00003532927],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.2273802,"threshold_uncertainty_score":0.9997236,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04438474684730338,"score_gpt":0.34782721431011,"score_spread":0.3034424674628066,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}